Navigation Links
Fuisz Pharma Announces Acquisition of Key Anti Opiate Abuse Patent to Complement its Anti Opiate Abuse Platform
Date:7/12/2010

MIAMI, July 12 /PRNewswire/ -- Fuisz Pharma today announced that it has acquired a key issued patent (US 7,214,385 "Pharmaceutical Formulation Containing Dye" (invented by Dr. Thomas Gruber)).  This patent covers the use of dyes and staining agents in pharmaceutical dosage forms as a method to prevent the improper use of opiate derived drugs by visually demonstrating their misuse.

Fuisz Pharma President, Joseph Matus Fuisz commented: "The technology described in the acquired patent is highly complementary to the anti abuse portfolio that we previously announced.  Importantly, the Gruber patent enables us to offer strong, existing patent protection for our partners.   We thus believe that this acquisition significantly enhances the value of our anti abuse platform and gives us a very strong IP position in the prevention of opiate abuse."

Mr. Fuisz continued: "This acquisition is also complementary to our next generation technology to aid and abet the absorption of all dosage forms including the ability to bring forth a very novel methodology to specifically play a critical role in the opiate agonist/antagonist pas de deux. This methodology is applicable to all dosage forms."

Noted pharmaceutical inventor Richard C. Fuisz, M.D. (http://en.wikipedia.org/wiki/Richard_Carl_Fuisz) is one of the principals of Fuisz Pharma.

Fuisz Pharma is a private pharmaceutical technology company originated by the Fuiszes. The Fuiszes have mad
'/>"/>

SOURCE Fuisz Pharma
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
2. Fuisz Pharma Announces Novel Anti Abuse System for Opiates
3. FUISZ Announces Advances in Devices and Solid Dosage Form
4. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 Today, Wall Street Reports announced ... GILD ), Health Management Associates Inc. (NYSE: HMA ... Pharmaceuticals Inc. (NASDAQ: ISIS ), and Trius Therapeutics ... of charge - including full price targets, industry analysis and ... Sciences, Inc. Research Report On June 7, 2013, ...
(Date:6/18/2013)... And EMERYVILLE, Calif. ... Inc. presented final results today from a Phase ... release) capsules demonstrating a statistically significant improvement in ... baseline at week 8 versus placebo in the ... investigational extended-release formulation of amantadine intended for once-nightly ...
(Date:6/18/2013)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ), the leader ... general corporate update in conjunction with its 2013 Annual Meeting ... 2:10 p.m. Pacific Time in Carlsbad, CA. ... follows: 2:00 p.m. – 2:10 p.m. Annual Meeting of Stockholders ... 2:10 p.m. – 3:15 p.m. Corporate Presentation – Stanley ...
Breaking Medicine Technology:Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House 2
(Date:6/18/2013)... "What if adding one simple act ... your health and well-being? Well, there is something easy ... "It is called Skin Brushing ." , Skin ... lost art. Now, people are rediscovering this great health ... so do certain health conscious people. Sublime Beauty® wants ...
(Date:6/18/2013)... New York, New York (PRWEB) June 19, 2013 ... dedicated to protecting the rights of victims injured by ... on behalf of an Arizona woman who alleges that ... The suit was filed on May 30th in the ... Virginia (Civil Action No. 2:13-cv-12677) in the multidistrict litigation ...
(Date:6/18/2013)... Looking for a way to break out of the ... IWALKAWAKE is a guide to unlocking one’s true potential through ... on harnessing the powerful and abundant spiritual presence that is ... guide to finding one’s true purpose and potential. These nine ... to reach their true potential. The awakenings deal with subjects ...
(Date:6/18/2013)... Daily Gossip Magazine has always kept its readers entertained by ... The magazine has decided to prepare readers for the summer ... every week . , According to Daily Gossip ... who are looking to get insights into this type of ... food is almost entirely based on healthy, yet tasteful products. ...
(Date:6/18/2013)... 18, 2013 SEATTLE, WA—A Washington state ... Fairview, Oregon, claiming he fell ill with a hepatitis ... pomegranate seed blend. The complaint was filed in ... Clark, the Seattle-based law firm that has filed ... to the complaint, Brian Brothers consumed “Townsend Farms Organic ...
Breaking Medicine News(10 mins):Health News:The Easiest Way to Contribute to Better Health and Well-Being Starting Today and for Under $20, Says Sublime Beauty® 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 3Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 4Health News:Anabolic Cooking Book Review Exposes Dave Ruel’s Top 10 ‘Anabolicious’ Recipes for BodyBuilders 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 3
... Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to ... the first nine months of 2008 on Pinksheets.com for ... the nine-months of 2008 amounted to $304,559, compared with ... substantially lowered its General and Administrative expense by posting ...
... U.S. Surgeon General Kenneth P. Moritsugu urged members of ... nutrition knowledge and patient-care skills to prevent diseases such ... that exist in the United States and to educate ... well-being.Moritsugu, who was Deputy Surgeon General from 1998 to ...
... announced today that Jean-Pierre Lehner , ... (CMO). He was previously Senior Vice President, Medical ... Vice President, Research & Development, who declared: "The ... further demonstration internally and externally of the company,s commitment ...
... Loeppke to discuss recent findings showing that ... medical and pharmacy costs-- Presentation includes real-world ... findings to develop integrated health and productivity ... arthritis and musculoskeletal disorders are significant cost ...
... 11 With a strong corporate commitment ... its partnership with the American Pregnancy Association, which ... "the official omega-3" of their organization. Also known ... leading non-profit in the United States that is ...
... and Drug Administration gave formal approval for the marketing of silicone ... all ages and breast augmentation procedures for patients over the age ... on the safety and effectiveness of silicone implants. , ... ...
Cached Medicine News:Health News:Solos Endoscopy, Inc. Posts First Nine Months Financials for 2008 on Pinksheets.com 2Health News:Registered Dietitians Can Do Much to Help Educate Americans and Eliminate Health Disparities in U.S., Says Former Surgeon General 2Health News:Registered Dietitians Can Do Much to Help Educate Americans and Eliminate Health Disparities in U.S., Says Former Surgeon General 3Health News:Jean-Pierre Lehner Appointed Chief Medical Officer 2Health News:Alere's Dr. Ron Loeppke to Speak on 'Health and Productivity as a Business Strategy' at First Annual IBI/NBCH Health and Productivity Forum 2Health News:Alere's Dr. Ron Loeppke to Speak on 'Health and Productivity as a Business Strategy' at First Annual IBI/NBCH Health and Productivity Forum 3Health News:Nordic Naturals Becomes the Official Omega-3 of the American Pregnancy Association 2Health News:Sacramento Breast Augmentation Surgeon Charles Perry, MD Discusses Silicone Implants on 2-Year Anniversary of FDA Approval 2Health News:Sacramento Breast Augmentation Surgeon Charles Perry, MD Discusses Silicone Implants on 2-Year Anniversary of FDA Approval 3
Shake 'n' Stack Oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual PLUS Shaker Platform)...
Inquire...
... 10.1 kg, Interior Dimensions (WxDxH): 31.1 x ... (WxDxH): 44.6 x 22.4 x 20.5 cm, ... 2 - 300 x 35 mm bottles, ... or 1 - 240 x 80 mm ...
... The Minifold I system consists of four basic ... plenum, and metal clamping plate (see diagram). The ... for producing spots, dots, or slots (see below). ... purchased as an accessory plate in conjunction with ...
Medicine Products: